SCHEMBL32688271

SCHEMBL32688271

N#Cc1c(-c2cccc(C(=O)Nc3ccccc3)c2)cc(=O)[nH]c1SCc1nnn[nH]1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.42
▸ HPGD P15428 3/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ NPC1 O15118 1/20 0.42
▸ TSHR P16473 1/20 0.42
▸ RAB9A P51151 1/20 0.42
▸ KMT2A Q03164 4/20 0.40
▸ POLB P06746 2/20 0.40
▸ MAPT P10636 2/20 0.39
▸ HDAC8 Q9BY41 1/20 0.39
▸ ACMSD Q8TDX5 1/20 0.38
▸ MET P08581 3/20 0.38
▸ KDR P35968 3/20 0.38
▸ SIRT2 Q8IXJ6 1/20 0.38
▸ KISS1R Q969F8 2/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ LMNA P02545 2/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ PKM P14618 1/20 0.38
▸ HTT P42858 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32688221 0.94 SIRT2 (0.46) SMN1; SMN2KMT2APOLBMAPTMET
SCHEMBL32688056 0.92 MET (0.41) ALDH1A1HPGDSMN1; SMN2KMT2APOLB
SCHEMBL32688358 0.91 PSMD14 (0.43) ALDH1A1TSHRPOLBMETKDR
SCHEMBL32688254 0.91 UGCG (0.40) NPC1RAB9AKMT2APOLBMAPT
SCHEMBL32688016 0.91 KISS1R (0.42) ALDH1A1KMT2APOLBMAPTMET
SCHEMBL32688247 0.89 ACMSD (0.44) ALDH1A1HPGDKMT2AACMSD
SCHEMBL32688124 0.88 ACMSD (0.42) ALDH1A1HPGDSMN1; SMN2NPC1TSHR
SCHEMBL32688478 0.88 ALDH1A1 (0.41) ALDH1A1HPGDSMN1; SMN2NPC1TSHR
SCHEMBL32688196 0.86 MAPK14 (0.38) ALDH1A1HPGDSMN1; SMN2KMT2AHDAC8
SCHEMBL32687986 0.85 KMT2A (0.39) ALDH1A1HPGDSMN1; SMN2KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors ORSOBIO INC (US) 2026-03-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors CPT1B, CBR1, MUSK ALDH1A1 290/4885HPGD 431/4885SMN1; SMN2 281/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback